1. Introduction {#sec1}
===============

Citrus plants derived from the single genus*Citrus* are largely interbreedable. Among the common names given to the various members of the citrus family, orange often refers to the most popular*Citrus sinensis* and*Citrus aurantium* \[[@B1]\]. Chemical composition of*Citrus* plants is characterized by the presence of several polyphenolic classes, including flavones, flavanones, flavonols, flavans, and anthocyanins \[[@B2], [@B3]\].

Experimental evidences highlight their pharmacological effects including antioxidant, cardioprotective, anti-proliferative, anticancer, and hypolipidemic activities \[[@B4]--[@B8]\].

In folk medicine, products derived from the peel and/or whole dried immature fruit of orange plants have been used to treat several health problems such as gastrointestinal disturbances, respiratory disorders as agent for cough \[[@B9]--[@B12]\], insomnia, stress disorders, epilepsy, and anxiety \[[@B12], [@B13]\].

Other citrus species such as*Citrus bergamia* have been described for their effects against stress, psoriasis, and hyperlipidemia \[[@B14]\]. The present article focuses on antianxiety preclinical and clinical effects of the two most common citrus species*Citrus aurantium*and*Citrus sinensis*.

*Citrus aurantium* L., also called Seville orange, sour orange, or bitter orange, is a small citrus tree, about five meters tall, with scented white flowers, belonging to Rutaceae family, originating in eastern Africa, Arabia, and Syria, and cultivated in Spain, Italy, and North America \[[@B1], [@B15]\].

*Citrus aurantium* is called with several local common names in different countries where it is used for food, fragrance, and medical application. Fruit, peel, leaves, flowers, seeds, and essential oil (EO) of*Citrus aurantium* are used in perfumes and cosmetics, as well as in the food and confectionery industry \[[@B16]\]. Bitter orange oil, obtained from the pressure of the fresh peels, is widely used as a flavoring agent in the food industry and for beverages, particularly liqueurs and soft drinks \[[@B17]\]. The composition of the volatile oils is significantly different in flowers, leaves, and peel. Linalyl acetate (50%) is the main constituent in oil from the leaves (petit grain), and linalool (35%) in oil is derived from the flowers (neroli) \[[@B18]--[@B20]\]. Flavones, alkaloids such as synephrine and octopamine, carotenoids, and N-methyltyramine are contained in peel, besides the volatile oil. The main active ingredient in bitter orange extract is the phenyl-ethylamine protoalkaloid p-synephrine which represents about 90% or more of the total protoalkaloids. Fruit peel contains a volatile oil composed of d-limonene, d-linalool, N-acetyl octopamine, gamma-aminobutyric acid, flavonoids, coumarins, triterpenes, vitamin C, carotene, and pectin \[[@B21]\]. Other minor protoalkaloidal constituents in*Citrus aurantium* octopamine, hordenine, tyramine, and N‐methyltyramine are absent or in trace amounts in bitter orange extracts \[[@B22]--[@B25]\].

Standardized aqueous-alcoholic extracts of the immature fruits of*Citrus aurantium* are widely consumed in dietary supplements for appetite control, weight management, sports performance, and energy, and bitter orange products are also consumed in the form of food as juices and marmalades \[[@B16], [@B26]\].

*Citrus aurantium* EO, also known as neroli oil, is widely used in aromatherapy. It has been suggested that it stimulates central nervous system, lowers blood pressure, and has sedative, analgesic, anti-inflammatory, antispasmodic, carminative, digestive, and diuretic effects \[[@B27]\]. It is a strongly scented bitter liquid, produced by hydrodistillation of*Citrus aurantium* fresh lives \[[@B28]\].

*Citrus sinensis* L., named orange or sweet orange, is a millennial small tree belonging to the Rutaceae (citrus) family originated in southern China. The orange tree is small, spiny tree, typically growing to 7.5 m, but occasionally reaching heights up to 15 m, generally with a compact crown. Orange tree grows in tropical, semitropical, and warm temperate regions, becoming the most widely cultivated fruit tree in the world \[[@B29], [@B30]\]. Orange is the world\'s most popular fruit and is eaten fresh or drunk as juice. Juice can be consumed directly or further processed into concentrate, and both derivatives are used in soda and cocktail drinks, punches, and liqueurs. Orange fruits and peels are also used in desserts, jams and marmalades, and candied peels, as well as cookies, cakes, and candies. EO derived from orange peels, flowers, leaves, and twigs is used in perfumes; orange seed oil may also be used in cooking or as a component in plastic industry \[[@B30]\].

The sweet orange tree is found more or less in the same places as the bitter orange tree. Sweet orange oil is extracted from the fruit of the tree via cold pressure; it is also possible to distill sweet orange oil \[[@B31]\].

*Citrus sinensis* contains several active secondary metabolites contributing to the pharmacological activities of the plant. In*Citrus sinensis* fruits, peel, leaves, juice, and roots, several types of chemical compounds including flavonoids \[[@B2], [@B32]\], hydroxyamides, steroids, alkanes and fatty acids, coumarins, carbohydrates, peptides, carbamates and alkylamines, carotenoids, volatile compounds, and minerals such as potassium, magnesium, calcium, and sodium have been identified \[[@B12], [@B33]\].

*C. sinensis* is a rich source of vitamin C, a natural antioxidant that support the immune system activity \[[@B33], [@B34]\].*C. sinensis* has been used traditionally, to treat intestinal disorders (such as cramps, constipation, colic, and diarrhea), respiratory disorders (such as cough, cold, bronchitis, and tuberculosis), obesity, menstrual disorder, cardiovascular disease (angina, hypertension), anxiety, depression, and stress \[[@B35]\].

Anxiety disorders are among the leading prevalent causes of global mental disorders \[[@B36], [@B37]\]. They contribute to favour poor compliance with therapy \[[@B38]\] and insufficient patient adoption of healthy behaviors \[[@B39]\]. On the basis of their negative effects on the results of therapy, it is necessary to find effective interventions.

It is known that inhalation of volatile components of*Citrus* EO is able to influence the activity of brain areas such as the hypothalamus, hippocampus, and pyriform; preclinical and clinical research showed that citrus fragrance can restore stress-induced cortex \[[@B40], [@B41]\] and immunosuppression \[[@B42]\] and may have potential antidepressant effects in rats \[[@B43], [@B44]\].

In light of the abovementioned findings, we tried to assess if the potential health effects of both*Citrus aurantium* and*Citrus sinensis* are really effective in the treatment of anxiety conditions. With this aim, we summarized the published reports of preclinical and clinical studies regarding the use of*Citrus aurantium- or Citrus sinensis*-based products in conditions related to anxiety disorders.

2. Methods {#sec2}
==========

2.1. Research Method and Inclusion Criteria of Clinical Trials {#sec2.1}
--------------------------------------------------------------

A bibliographic research was carried out independently by two researchers (blinded to the authors and initially on results) in the major scientific databases and search engines of peer-reviewed literature from 2000 to July 2018, on life sciences and biomedical topics (PubMed, Scopus, Embase, Web of Science, and Google Scholar). The following keywords or combination of keywords "Citrus anxiety", "*Citrus aurantium* axiety", "*Citrus sinensis anxiety"*, and "clinical trials" were used. Analysis included only articles written in English and published on peer-reviewed scientific journals describing clinical trials and applications of*Citrus aurantium* or*Citrus sinensis* EOs. Articles describing the effects of products containing*Citrus aurantium* or*Citrus sinensis* EOs in combination with other active substances including medicinal plants derivatives were also excluded. The selection and the review of clinical studies written in English regarding*Citrus aurantium* or*Citrus sinensis* EOs were performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement \[[@B45]\]. Methodological quality was assessed using validated tools such as the Consort Statement in Reporting Clinical Trials with Herbal Medicine Intervention ([Section 4](#sec4){ref-type="sec"}) \[[@B46]\] and the Jadad Scale \[[@B47]\]. From the eligible articles, two investigators independently extracted data by using a standard data extraction form. Data were considered for therapeutic indication, design of the study, number, sex, and age of subjects, endpoints, adverse effects, and outcome. In all the studies, reporting of adverse reactions was monitored. The absence of adverse reactions was defined as "not reported." All the authors reviewed all the eligible articles and resolved by discussion any uncertainty regarding the statistical method used to handle the missing data.

3. Results {#sec3}
==========

A collection of 94 scientific articles was selected from our bibliography research. Only 17 articles describing effects of*Citrus aurantium*or*Citrus sinensis* treatment for anxiety were corresponding to the inclusion criteria. 63 articles were excluded for title and abstract and 4 were excluded because the products object of the studies were combinations including*Citrus aurantium*.

Nine clinical studies were included in the review ([Figure 1](#fig1){ref-type="fig"}). In eight clinical studies,*Citrus aurantium*or*Citrus sinensis* were administered for inhalation as aromatherapy, and in one study*Citrus aurantium* was orally administered.

[Table 1](#tab1){ref-type="table"} summarizes for each preclinical study the authors, the route of administration, animal species, experimental model to study anxiety, dose, and observed effects of*Citrus aurantium*or*Citrus sinensis*administration. Tables [2](#tab2){ref-type="table"} and [3](#tab3){ref-type="table"} summarize authorship of the paper, therapeutic indication, study design, subjects involved, endpoints, adverse effects, and outcome of all the clinical trials regarding use of*Citrus aurantium*or*Citrus sinensis*, respectively. Tables [4](#tab4){ref-type="table"} and [5](#tab5){ref-type="table"} report CONSORT items for trials with herbal medicine interventions applied to clinical studies, for*Citrus aurantium* and*Citrus sinensis*, respectively. [Table 6](#tab6){ref-type="table"} reports quality assessment of randomized controlled trials by the Jadad scoring system.

3.1. Citrus aurantium (Sour/Bitter Orange) Preclinical and Clinical Antianxiety Effects {#sec3.1}
---------------------------------------------------------------------------------------

Antianxiety effects of*Citrus aurantium* were demonstrated through behavioral experiments carried out with laboratory animals.*C. aurantium* EO oral administration in mice increased exploration of the open arms (time spent) in the elevated plus-maze at a dose that did not impair motor activity observed with open-field and rotarod test, which is indicative of anxiolytic-like effect in male mice \[[@B48]\].

The acute administration induced an anxiolytic-like effect in the light/dark transition tests (increased time spent in the light side, and in the number of transitions) and in marble burying (decreased number of marbles buried) without any motor impairment, while repeated administration showed effects in the marble-burying test only. Repeated diazepam administrations did not increase light/dark transitions. Thus, the results suggest an anxiolytic-like effect following acute and repeated*Citrus aurantium* EO administration \[[@B49]\].

Similar results were obtained in another experiment showing that anxiolytic-like effect of oral administration of*Citrus aurantium* EO was reversed by 5-HT1A antagonist WAY100635 but not by flumazenil, a benzodiazepine antagonist, suggesting serotonergic mediation \[[@B44]\].

In another study, inhalation of*Citrus aurantium*EO increased social interactions (time spent in active social interaction) in rats and increased exploration time in the open arms of the elevated plus-maze, suggesting an anxiolytic-like effect at a dose that did not impair motor activity in the open-field test \[[@B51]\].

Acute intraperitoneal administration of*Citrus aurantium* EO, similar to fluoxetine, increased open arm explorations (percentage of time spent and percentage of entries) in the elevated plus-maze in male mice. The authors suggested that the effect of*Citrus aurantium* L. is linked to serotonergic transmission based on a fluoxetine +*Citrus aurantium* EO interaction. However,*Citrus aurantium* EO did not change the anxiolytic effect of fluoxetine in the elevated plus-maze, suggesting no drug interaction \[[@B52]\].

Khosrovi et al. investigated the effect of intraperitoneal injection of*Citrus aurantium*EO on anxiety and its interaction with GABAergic pathways, evaluating the coadministration effects of*Citrus aurantium* and diazepam. Results showed that*Citrus aurantium* EO increased the open arms exploration (increase of percentage time spent) of male mice submitted to the elevated plus-maze. Although diazepam increased open arms exploration (percentage of time spent and percentage of entries), coadministration with*Citrus aurantium* reduced the anxiolytic effect of diazepam. Flumazenil did not alter the effect of*Citrus aurantium*; however, authors suggest that*Citrus aurantium* L. may exert an anxiolytic-like effect acting as partial agonist at the GABA-A receptor/benzodiazepine site \[[@B53]\]. Preclinical antianxiety effects of*Citrus aurantium* are summarized in [Table 1](#tab1){ref-type="table"}.

Complex six studies investigating*Citrus aurantium* EO effects on anxiety levels during different medical conditions were found. All of the six studies in which*Citrus aurantium* was investigated were randomized/controlled clinical trials.

One randomized clinical trial described the effects of*Citrus aurantium*EO in reducing anxiety during labor in a group of Iranian pregnant women \[[@B54]\].

Before the aromatherapy, both groups had the same levels of anxiety; the levels of anxiety evaluated at dilations of 3-4 and 6-8 cm were significantly lower in the aromatherapy group with*Citrus aurantium* compared with the control group, thus suggesting that aromatherapy with*Citrus aurantium*EO could reduce anxiety during labor \[[@B54]\].

A trial was carried out on patients proposed for colonoscopy and divided into two groups. Aromatherapy was performed by inhalation of Sunflower oil (control group) and Neroli oil (experimental group). Results showed that there was no significance difference of procedural anxiety measured by State Trait Anxiety Inventory state (STAI-S) score and procedural pain evaluated by visual analogue scale (VAS), before and after aromatherapy in patients subjected to colonoscopy. Significant lower pre- and postprocedural systolic blood pressure in Neroli group than control group were observed. The authors concluded that the inhalation aromatic agent had an effect on lowering procedural anxiety-related (excessive fear of medical, dental, or surgical procedures that results in acute distress or interference) blood pressure \[[@B55]\].

Patients with a mandibular third molar with B II classification of impacted teeth and American Society of Anaesthesiologists (ASA) class I patients (healthy subjects with no organic pathology), with moderate and high anxiety levels measured through the dental anxiety scale (DAS) questionnaire, were included in another randomized and controlled study.

The ASA clinical status classification system assessed the fitness of patients before surgery. The outcome variables were physiologic measures related to anxiety, including mean blood pressure, respiratory rate, and pulse rate.

After aromatherapy, mean blood pressure, pulse rate, and respiratory rate were significantly lower in the fragrance group during surgery (from the time of sitting in the dental chair to the end of surgery). Vital signs measurements showed significant differences between the two groups, which may be due to the sedative effect of the orange fragrance during surgery. Results suggest that ambient orange fragrance could be helpful in reducing dental anxiety during dental surgical removal \[[@B56]\].

Another study was carried out on a Brazilian volunteers\' cohort with chronic myeloid leukemia (CML), treated with standard therapy. The study compared*Citrus aurantium* EO with diazepam anxiolytic effects, in the moment that precedes the collection of medullary material in patients with CML. Systolic and diastolic blood pressure and cardiac and respiratory frequencies were measured.*C. aurantium* EO decreased both systolic and diastolic blood pressure while with diazepam, only systolic blood pressure decreased. The*Citrus aurantium* EO did not decrease the respiratory frequencies.

The use of STAI-S revealed an anxiolytic effect of*Citrus aurantium* EO group of patients with CML but not in the CML diazepam and placebo groups. In conclusion, study results showed an anxiolytic effect of*Citrus aurantium*EO in patients with CML with an improvement of psychological and physiologic parameters. For the authors, this effect has a great clinical relevance, because patients with cancer go through various stressful phases during the disease, and the standard therapy significantly contributes to improve the anxiety level and physiological parameters during a procedure that is a cause of distress \[[@B13]\].

Chaves Neto et al. (2017) studied the anxiolytic effects of*Citrus aurantium* EO in patients experiencing crack withdrawal. Based on the fact that individuals who experience crack withdrawal present a high anxiety trait, anxiety status was induced with the Simulated Public Speaking (SPS) method (subject is requested to deliver a speech in front of a video camera with its image being displayed on a TV screen). Anxiety levels were assessed by the Inventário de Ansiedade Traço-Estado (IDATE), the Brazilian version of STAI-S.

The results demonstrated that subjects in the groups treated with*Citrus aurantium* EO maintained controlled anxiety levels during SPS when compared to the control group (no treatment). Subjects who were administered*Citrus aurantium* EO also maintained states of discomfort and cognitive impairment often associated with anxiety during SPS. However, nebulization of the EO of*Citrus aurantium*provided an acute anxiolytic effect in crack cocaine users exposed to SPS.

Authors\' conclusions were that*Citrus aurantium* EO, administered by nebulization, produced anxiolytic effects in crack users in abstinence thus indicating the possibility of*Citrus aurantium* EO use as an alternative complementary therapy in the control of anxiety in users who are abandoning drugs abuse \[[@B57]\].

In a randomized double-blind design, the effect of oral administration of*Citrus aurantium* blossom distillate (CABd) on preoperative anxiety was evaluated. Preoperative anxiety was assessed using STAIS and Amsterdam Preoperative Anxiety and Information Scale (APAIS). The main finding of this study was the confirmation of the anxiolytic effect obtained with oral administration of blossom distillate*Citrus aurantium*. Both STAI-state and APAIS scores were decreased by CABd. On the other hand, neither STAI-state nor APAIS was changed in the placebo group \[[@B58]\].

Results of the studies using*Citrus aurantium* EO showed that inhalation of the oil produces significant anxiolytic effects. Methods for diffusion of EO used in the studies are by direct inhalation with hand-hold nebulizers generally with doses of EO ranging 10 -- 50 mL or by dilution of EO in distilled water and successive diffusion through an electric dispenser or by gauzes impregnated with 4 mL of*Citrus aurantium* EO.

3.2. Citrus sinensis (Sweet Orange) Pre-Clinical and Clinical Anti-Anxiety Effects {#sec3.2}
----------------------------------------------------------------------------------

In comparison to findings published about investigation on*Citrus aurantium*, a reduced number of preclinical and clinical experiments were conducted on*Citrus sinensis*. Inhalation of*Citrus sinensis* EO (sweet orange, containing 97% limonene) in rats submitted to elevated plus-maze followed by the light/dark paradigm produced an increase in open arm exploration (% time spent and % number of entries) in the elevated plus-maze, and of the time spent in the lit chamber of the light/dark test. No effect on motor activity, as measured by the total distance travelled in the elevated plus-maze, was detected \[[@B59]\].

Anxiolytic‐like, sedative, and antidepressant‐like potential effects of inhalation of both*Citrus aurantium* and*Citrus sinensis* EOs were evaluated through behavioral tests and measurement of corticosterone and melatonin plasma levels in mice.

Results of behavioural tests showed an anxiolytic‐like and sedative effect of*Citrus sinensis* EO 10% inhalation, without affecting melatonin and corticosterone physiological levels. Inhalation of 10%*Citrus aurantium* EO did not show neither anxiolytic-like effects nor change in melatonin and corticosterone plasma levels \[[@B60]\].

Three randomized and controlled studies investigating on the effects of*Citrus sinensis* were found. Two studies describe the effects of*Citrus sinensis* EO on anxiety in adults and children, respectively, subjected to dental treatments.

A randomized controlled trial was carried out on adult patients waiting for dental treatment to evaluate the anxiolytic effects of*Citrus sinensis*. Orange odor was diffused in the waiting room of odor group through an electrical dispenser whereas in the control group no odor was diffused. For assessing cognitive functions, patients completed the Wortschatz test (WST) \[[@B61]\]. For assessing trait and state anxiety, patients were given the State-Trait Anxiety Inventory (STAI) \[[@B62]\]. The Mehrdimensionale Befindlichkeitsfragebogen (MDBF) \[[@B63]\] were used for assessment of current mood, alertness, and calmness.

Results of the study showed that exposure to ambient orange odor has a relaxant effect compared to control group. Results reported also a sex difference of*Citrus sinensis* effects, showing that women exposed to sweet orange EO had a lower level of state anxiety, a more positive mood, and a higher level of calmness \[[@B64]\].

The effects of orange odor (*Citrus sinensis*) on child anxiety during dental treatment were also evaluated in another study by using salivary cortisol and pulse rate as index of patients\' anxiety.

The results of this study showed that the salivary cortisol level and pulse rate significantly decreased in intervention groups by using aromatherapy with*Citrus sinensis* EO \[[@B65]\]. The potential anxiolytic effect of*Citrus sinensis* EO was evaluated in a double-blind, randomized, placebo-controlled clinical trials carried out on healthy volunteers submitted to an anxiogenic situation. Immediately after inhalation, each subject was submitted to the video-monitored version of the Stroop Color-Word Test (SCWT), a method to induce anxiety. During the text, a board with 100 of the color-naming words blue, yellow, red, green, and violet organized randomly in a 10 · 10 matrix is presented to each participant. The color of each word is different from its own meaning (for example, the word "green" printed in red). The participant has to say quickly (in two minutes) the sequence presented, the color of the ink, but not the colors described by the single words. The whole test is recorded and presented to the subject on a monitor during the test \[[@B66]\].

State-Trait Anxiety Inventory (STAI) and Visual Analogue Mood Scale (VAMS) were used to evaluate psychologic parameters. Physiologic parameters were evaluated before the inhalation period and before, during, and after the SCWT. Results showed dose-dependent anxiolytic properties of sweet orange EO \[[@B66]\].

These three studies indicate that*Citrus sinensis* EO exerts anxiolytic effects in anxiogenic situations. One of the studies show that*Citrus sinensis* EO exerts its anxiolytic effects also in children.

4. Discussion {#sec4}
=============

EOs physiological and psychological effects are known in folk medicine and aromatherapy for a long time \[[@B14], [@B67]\]. Aromatherapists have proposed that*Citrus* fragrances have mood-enhancing properties. These effects were confirmed by successful clinical study carried out with citrus fruits oils on patients affected by stress symptoms or depression \[[@B68], [@B69]\].

Anxiety disorders are the most common type of psychiatric disorders in the general population \[[@B70]\]. Their treatment is difficult because of the important side effects of the drugs used to improve anxiety symptoms, which generally promote dependence \[[@B71]\]. Moreover, common treatments do not benefit all patients and only few of them have a slight resumption \[[@B72]\]. These conditions justify the increasing interest and search for alternative or complementary procedures aimed at improving anxiety symptoms. One of these is aromatherapy, a procedure that uses EOs by inhalation as a treatment for medical purposes \[[@B73]\].

*Citrus aurantium* and*Citrus sinensis*are rich in flavonoids and polyphenolic compounds with numerous pharmacological properties, such as the inhibition of the oxidation of low-molecular weight proteins and platelet accumulation thus contributing to immune cell stability.

They are also used in treatment of mental disorders, inflammation, viral infections, and allergies \[[@B74], [@B75]\]. Flavonoids effects in reducing anxiety are due to their action as benzodiazepine receptor agonists \[[@B58]\].

A series of review articles regarding the safety and efficacy of bitter orange has been published \[[@B76]--[@B79]\]. However, this is the first analysis of clinical studies using*Citrus aurantium* or*Citrus sinensis* for the treatment of anxiety. We analyzed all clinical studies according to the recommendations described in the checklist developed by the Consolidated Standards of Reporting Trials \[[@B46]\] for the reporting of clinical trials using herbal medicinal products (Tables [4](#tab4){ref-type="table"} and [5](#tab5){ref-type="table"}). The clinical trials included in this review have different levels of methodological accuracy. All of studies were randomized and controlled. Only one study regarding*Citrus aurantium*use was carried out with a double-blind methodology ([Table 2](#tab2){ref-type="table"}). Two of the studies regarding*Citrus sinensis* use were carried out with a double-blind methodology, and only one was performed as a crossover study ([Table 3](#tab3){ref-type="table"}).

Since it is a common source of selection bias, a point of weakness in all the studies is the lack of description of the methods adopted to generate random allocation sequences \[[@B79]\] ([Table 6](#tab6){ref-type="table"}). Moreover, all the studies were poor in number of subjects recruited. In four of them, the sample of people recruited did not exceed 50 patients, in four studies, the samples exceeded 50 participants, and only in one study the sample was more than 100 patients (Tables [2](#tab2){ref-type="table"} and [3](#tab3){ref-type="table"}).

All the studies reported statistical data analysis but no one reported sample size calculation. Latin binomial name of the plant was always correctly reported, although not all articles provided an exhaustive description of the characteristics of the product. Procedure adopted to obtain the EO and description of the raw material used to produce the herbal preparations were reported only in one study (Tables [4](#tab4){ref-type="table"} and [5](#tab5){ref-type="table"}). The highest standards in methodology for clinical trials in herbal medicine strongly recommend the reporting of the characteristics of the product to facilitate the reproducibility of the studies. The presence of these data are fundamental to establish a link between the putative efficacy and safety to the single product \[[@B46]\].

Only few studies report qualitative testing producing the chemical fingerprint of the herbal products ([Table 4](#tab4){ref-type="table"}). Finally, one study \[[@B13]\] compares the effects of*Citrus aurantium* against diazepam, a well-established drug prescribed for the treatment of anxiety ([Table 2](#tab2){ref-type="table"}).

5. Conclusions {#sec5}
==============

Antianxiety effects of*Citrus aurantium* and*Citrus sinensis* EOs were previously demonstrated through behavioral experiments carried out on laboratory animals. Complex clinical studies considered for this overview suggest that*Citrus aurantium* or*Citrus sinensis* EOs, used for anxiolytic therapy of people prevalently in conditions in which stress is dominating, produce positive effects against anxiety. In particular,*Citrus aurantium* EO aromatherapy reduced anxiety level in the great part of stress conditions studied (subjects affected by chronic myeloid leukemia and preoperative patients) except for a sample of patients subjected to colonoscopy. Exposition to*Citrus sinensis* EO in clinical studies is shown to be positive in reducing anxiety level in patients waiting for dental treatment as well as in healthy volunteers submitted to an anxiogenic situation. However, a definitive conclusion needs further studies because of the reduced number of studies and the small number of patients for each study. Regarding data reporting of clinical studies with*Citrus aurantium*, they appear without description of the characteristics of the herbal product and lack qualitative testing. From the methodological point of view, most of the clinical studies show the lack of important items such as treatment allocation conceal and description of double-blind procedure. On the basis of the present overview, we can conclude that the use of*Citrus aurantium* and*Citrus sinensis* EOs could be useful to reduce anxiety caused by clinical stress conditions; however, results are impaired by the poor accuracy and methodology applied in clinical studies.
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###### 

Principal characteristics of pre-clinical studies carried out with *Citrus aurantium* or *Citrus sinensis* essential oil.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Species**                               **Authors**                        **Preparation**                                         **Route of administration**   **Species**                     **Anxiety Model**                                                                                                                                                                                                                             **Dose**                                                                                                                                                                                                                                                                                                                        **Observed Effect**
  ----------------------------------------- ---------------------------------- ------------------------------------------------------- ----------------------------- ------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ***Citrus aurantium***                    Carvalho and Costa, 2002           *Citrus aurantium* essential oil                        Gavage oral administration    Male Swiss mice                 Pentobarbital Sleeping Time (induced by sodium pentobarbital 40 mg/kg, i.p.)\                                                                                                                                                                 Animals were orally treated with *Citrus aurantium* essential oil (0.5 or 1.0 g/kg), extract or fractions (HE, HF, DF and AF at 1.0 g/kg) 30 min before the experiments for the evaluation of the sedative/hypnotic activity, anxiolytic activity (elevated plus maze and anticonvulsant activity or by maximal electroshock.   *Citrus aurantium* 1.0 g/kg increased the sleeping time induced by barbiturates and the time spent in the open arms of the EPM.\
                                                                                                                                                                                                     Elevated Plus Maze Test (EPM)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Both doses of preparation used did not promote deficits in general activity or motor coordination. HF and DF fractions (1.0 g/kg) did not interfere in the epileptic seizures but were able to enhance the sleeping time induced by barbiturates.
                                                                                                                                                                                                     Open Field Test\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                     \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                     Rota-Rod Test\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                     \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                     Convulsing Tests (induced by subcutaneous injection of pentylenetetrazole -- 85 mg/kg).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Leite et al., 2010                        *Citrus aurantium* essential oil   Inhalation                                              Male Wistar rats              Open-field behavioral test\     *Citrus aurantium* essential oil was administered at the concentrations of 1.0%, 2.5% and 5.0%, w/w, for 7 minutes.\                                                                                                                          *Citrus aurantium*essential oil at the concentration of 2.5% increased both the time of the animals in the open arms of the EPM and the time of active social interaction in the open-field being longer than that of the diazepam group.                                                                                       
                                                                                                                                                                     Social interaction test\        Control groups: saline, or diazepam 1.5 mg/ kg i.p.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                     Elevated plus-maze test (EPM)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Costa et al., 2013                        *Citrus aurantium* essential oil   Gavage oral administration                              Male Swiss mice               Light/Dark Box Test\            *Citrus aurantium* essential oil was administered as single dose (5 mg/kg) or 14-day repeated dose (1 mg/kg/day).                                                                                                                             *C. aurantium* EO possesses a significant anxiolytic-like activity, and the present results strongly suggest the involvement\                                                                                                                                                                                                   
                                                                                                                                                                     Rotarod Test (RRT)\                                                                                                                                                                                                                                                           of 5-HT1A-receptors.                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                     Forced Swim Test (FST)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Pultrini et al., 2006                     *Citrus aurantium* essential oil   Gavage oral administration                              Male Swiss mice               Light--dark box test\           Citrus aurantium essential oil 0.5 or 1.0 g/kg in a volume of 10 ml/kg.                                                                                                                                                                       In light--dark box test, single treatment with essential oil (0.5 or 1.0 g/kg) increased the time spent by mice in the light chamber and the number of transitions between the two compartments.\                                                                                                                               
                                                                                                                                                                     Marble-burying test\                                                                                                                                                                                                                                                          Single and repeated treatments with essential oil (0.5 or 1.0 g/kg) were able to suppress marble-burying behavior.\                                                                                                                                                                                                             
                                                                                                                                                                     Rotarod test\                                                                                                                                                                                                                                                                 \                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                   No impairment on rotarod procedure after both single and repeated treatments with essential oil was observed, denoting absence of motor deficit.                                                                                                                                                                                

  Khosravi et al., 2014\                    *Citrus aurantium* essential oil   Intraperitoneal injection                               Male albino mice              Elevated plus-maze test (EPM)   Intraperitoneal injection of *Citrus aurantium*L. essential oil was administered at different doses (0.5, 2.5, and 5 percent) for 5 days.\                                                                                                    In groups receiving *Citrus aurantium*L. essential oil at doses of 2.5 and 5 %, there was a significant increase in percent of time spent in the open arms.\                                                                                                                                                                    
                                                                                                                                                                                                     Diazepam (0.1 mg/kg) was injected on the fifth day, thirty minutes before *Citrus aurantium*L. essential oil administration.\                                                                                                                 The injection of diazepam alone or with *Citrus aurantium*L. essential oil caused an increase in the number of entries and the percent of time spent in the open arms.\                                                                                                                                                         
                                                                                                                                                                                                     \                                                                                                                                                                                                                                             \                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                     Control and sham group received olive oil.                                                                                                                                                                                                    The results of this study show that *Citrus aurantium*L. essential oil can reduce anxiety-related behaviors in male mice that may act via GABAergic system.                                                                                                                                                                     

  Saketi et al., 2014                       *Citrus aurantium* essential oil   Intraperitoneal injection\                              Male albino mice\             Elevated plus maze test\        *Citrus aurantium*L. essential oil was administered at doses of 0.5, 2.5, and 5 percent for 5 days.\                                                                                                                                          Injection of *Citrus aurantium*L. essential oil, alone or along with fluoxetine, increased the number of entries into the open arms and the time spent in open arms that may act via serotonergic system.\                                                                                                                      
                                                                                                                                                                                                     In another set of experiments, after intraperitoneal injection of *Citrus aurantium*L. essential oil at doses of 0.5, 2.5, and 5 percent for 5 days, on day 5, 30 minutes before applying essential oil, fluoxetine (2 mg/kg) was injected.                                                                                                                                                                                                                                                                                                                                   

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  *Citrus sinensis*                         Faturi et al., 2010                *Citrus sinensis* essential oil                         Inhalation                    Male Wistar rats                Elevated plus-maze\                                                                                                                                                                                                                           *Citrus sinensis* essential Oil was administered at 100, 200 and 400 *μ*l.\                                                                                                                                                                                                                                                     All doses of *Citrus sinensis* oil demonstrated anxiolytic activity in at least one of the tests and, at the highest dose, it presented significant effects in both animal models, as indicated by increased exploration of the open arms of the elevated plus-maze and of the lit chamber of the light/dark.
                                                                                                                                                                                                     Light/dark paradigm                                                                                                                                                                                                                           Control groups were intraperitoneally injected with diazepam (2 mg/kg) or saline, in an injection volume of 10 ml/kg, 30 min before the behavioural tests.                                                                                                                                                                      

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  *Citrus aurantium* or *Citrus sinensis*   Wolffenbüttel et al., 2018         *Citrus aurantium* or *Citrus sinensis* essential oil   Inhalation                    Male adult albino mice          Light-- dark test\                                                                                                                                                                                                                            10% (v/v*) Citrus aurantium* leaves\' EO\                                                                                                                                                                                                                                                                                       Behavioral tests showed that\
                                                                                                                                                                                                     Locomotor activity test\                                                                                                                                                                                                                      10% (v/v) of *Citrus sinensis* peel EO was administered.\                                                                                                                                                                                                                                                                       the inhalation of 10% *Citrus sinensis* EO presents an anxiolytic‐like and sedative effect.\
                                                                                                                                                                                                     \                                                                                                                                                                                                                                             \                                                                                                                                                                                                                                                                                                                               Vaporization of 10% *Citrus aurantium* EO for 30 min by mice did not produce anxiolytic‐like or sedative effects.\
                                                                                                                                                                                                     Tail‐suspension test\                                                                                                                                                                                                                         Tween 80 (1% v/v in distilled water) inhaled solution or intraperitoneal injection of diazepam 2.0 mg/kg, or intraperitoneal injection of 20.0 mg/kg imipramine, or intraperitoneal injection of saline solution (0.9% NaCl) was used as control.                                                                               \
                                                                                                                                                                                                     \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Inhalation of *Citrus aurantium*and\
                                                                                                                                                                                                     Melatonin (MEL) and corticosterone (CORT) assay                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               *Citrus sinensis* EO did not affect MEL and CORT plasma levels in mice.
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Principal characteristics of clinical studies carried out with *Citrus aurantium* essential oil.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Authors**                       **Indication**                                                                                            **Study** **design**                       **Subjects (number and age)**                                                                                                **Treatment**                                                                                                                                                                                                                                            **Principal endpoints**                                                                                                                                                                                                                                                                                                                                             **Adverse** **effects**   **Outcome**
  --------------------------------- --------------------------------------------------------------------------------------------------------- ------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------
  Fernandes Pimenta, et al., 2016   Anxiety in patients with chronic myeloid leukemia (CML)                                                   Randomized controlled study                N = 42 of both sexes.\                                                                                                       Participants were randomly divided into three groups.\                                                                                                                                                                                                   The evaluation was performed through psychometric scales STAI-S \[State-Trait Anxiety Inventory (STAI)\] and physiological measurements (blood pressure and cardiac and respiratory frequency).\                                                                                                                                                                    Not reported.             Inhalation of *C. aurantium* was associated with a decrease in\
                                                                                                                                                                                         Average age: 45 ± 5 years.\                                                                                                  Group 1 received 10 mg diazepam as oral dose;\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         the STAI-S scores, suggesting an anxiolytic effect.\
                                                                                                                                                                                                                                                                                                                      Group 2 received *C. aurantium* essential oil (EO) 10 mL diffused in the room through an electric dispenser.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          In patients exposed to *C. aurantium*EO or with diazepam, there was a decrease in the systolic blood pressure.\
                                                                                                                                                                                                                                                                                                                      Group 3 (placebo) was exposed to the vaporization of saline solution.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 A change in all the physiological\
                                                                                                                                                                                                                                                                                                                      In the last two groups, the exposure lasted 30min.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     measurements was observed in the group exposed to *C. aurantium*.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             The results showed that\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             *C. aurantium* exhibits an anxiolytic effect and reduces the signs and symptoms associated with anxiety in patients\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             with CML.

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Pei-Hsin et al., 2010             Anxiety, stress and physiological parameters in patients subjected to colonoscopy                         Randomized controlled trial.               N = 27 subjects:\                                                                                                            Aromatherapy\                                                                                                                                                                                                                                            The anxiety index\                                                                                                                                                                                                                                                                                                                                                  Not reported              There was no\
                                                                                                                                                                                         13 in control group and 14 in Neroli group.\                                                                                 was then carried out by inhalation of Sunflower oil\                                                                                                                                                                                                     was evaluated by STAI-S before aromatherapy and after colonoscopy;\                                                                                                                                                                                                                                                                                                                           significant difference of procedural anxiety by STAI-S score\
                                                                                                                                                                                         Average age: 52.26 ± 17.79 years.                                                                                            (control group) and Neroli oil (experimental group).\                                                                                                                                                                                                    postprocedural pain index was measured by visual analogue scale (VAS).\                                                                                                                                                                                                                                                                                                                       and procedural pain by VAS before or after aromatherapy. The physiological\
                                                                                                                                                                                                                                                                                                                      One drop (50 ml) of Sunflower oil or Neroli oil placed in handhold-nebulizer was supplied for five minutes.                                                                                                                                              Systolic and\                                                                                                                                                                                                                                                                                                                                                                                 parameters showed a significant lower pre- and postprocedural systolic blood pressure in Neroli group than control group.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               diastolic blood pressure, heart rate and respiratory\                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               rate were evaluated before and after aromatherapy.                                                                                                                                                                                                                                                                                                                                            

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Akhlaghi et al., 2011             Anxiety in ASA\                                                                                           Randomized controlled double-blind study   60 outpatients, scheduled for elective minor surgery\                                                                        Participants were divided into two groups of 30 receiving oral *Citrus aurantium* blossom distillate (CABd 1 mL.kg-1) or placebo, respectively, two\                                                                                                     Preoperative anxiety\                                                                                                                                                                                                                                                                                                                                               Not observed.             Patients treated with CABd were significantly less anxious than patients of placebo group (p \< 0.05).
                                    physical status I (healthy) patients scheduled for lower limb minor operation\                                                                       Age range: 15-60 years.                                                                                                      hours before surgery.                                                                                                                                                                                                                                    was assessed using both State-Trait Anxiety Inventory (STAI state)\                                                                                                                                                                                                                                                                                                                           
                                    under general anesthesia.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 and Amsterdam Preoperative Anxiety and Information\                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Scale (APAIS). Heart rate and\                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               blood pressure were measured two hours before\                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               operation just before premedication.                                                                                                                                                                                                                                                                                                                                                          

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Hasheminia et al., 2014           Moderate and high anxiety before and during surgical removal of an impacted\                              Randomized controlled clinical trial.      N = 56;\                                                                                                                     Patients were divided into two groups: fragrance group (19 males, 9 females), control group\                                                                                                                                                             The dental anxiety scale (DAS) questionnaire was used to determine the anxiety level of the patients prior to surgery\                                                                                                                                                                                                                                              Not reported              Orange fragrance is effective in reducing anxiety linked to surgical\
                                    mandibular third molar.                                                                                                                              Age range: 15-45; mean age fragrance group: 26.4 ± 5.3 years, mean age no fragrance group: 27.5 ± 5.7 years.                 (12 males, 16 females).\                                                                                                                                                                                                                                 Mean blood pressure, respiratory rate, and pulse rate were also evaluated.                                                                                                                                                                                                                                                                                                                    removal of impacted mandibular third molar. Mean blood pressure, respiratory rate, and pulse rate, during surgery, were significantly reduced.
                                                                                                                                                                                                                                                                                                                      Patients of the fragrance condition were exposed to 5 drops (0.25 mL) of *C. aurantium* essential oil poured in 5 L of water and diffused using an electrical dispenser.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                      Patients in the control condition were exposed in the same environment to diffusion of water without fragrance. All the patients (control and experimental) waited about 10 min in the waiting room.                                                                                                                                                                                                                                                                                                                                                                                                                                                   

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Namazi et al., 2014               Anxiety during labor in primiparous pregnant women.                                                       Randomized controlled trial                126 primiparous women divided into two groups: aromatherapy (n = 63) and control (n = 63).\                                  100 mL of the distillate contained 8 mL *C. aurantium*essential oil. Gauzes impregnated with 4 mL of *C. aurantium*distillate and normal saline were attached to the collar of the participants in the aromatherapy and control groups, respectively.\   Intensity of anxiety was measured at baseline and after the intervention at dilations of 3-4 and 6-8 cm. Data were collected using a demographic and obstetric questionnaire, an examination and observation checklist including vital signs, vaginal examination, uterine contractions, and fetal heart rate, and Spielberger state-trait anxiety questionnaire.   Not observed              The levels of anxiety at dilations of 3-4 and 6-8 cm were significantly lower in the aromatherapy group compared with the control group.
                                                                                                                                                                                         Age range: 18-35 years. Mean age: 26.43 ± 3.21 aroma therapy group; 26.60 ± 3.40.\                                           The gauzes were changed every 30 minutes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Chaves Neto et al., 2017          Anxiolytic effect of *Citrus aurantium L*. in Crack Users subjected to Simulated Public Speaking (SPS).   Randomized controlled clinical trial.      51 volunteers,\                                                                                                              *Citrus aurantium* essential oil was administered by nebulization, 2 drops\                                                                                                                                                                              The Simulated Public Speaking (SPS) method was used. Physiological measures were assessed at specific phases during the experiment.\                                                                                                                                                                                                                                Not reported              Nebulization of C*itrus aurantium* L. EO provided an acute anxiolytic effect in crack cocaine users exposed to SPS.
                                                                                                                                                                                         subdivided into three groups:\                                                                                               (0.1 mL) in 1.9mL of distilled water solution with an emulsifier (Tween 80 at 12%), for each subject.\                                                                                                                                                   Psychological measures of anxiety were assessed using the Trait-State Anxiety Inventory (IDATE) and the Humor Analog Scale (HAS).\                                                                                                                                                                                                                                                            
                                                                                                                                                                                         Control Group: non-crack users who were not internal to the therapeutic communities (n=17) mean age of 28 years (± 2.01);\   Control Group experienced received only the distilled water with an emulsifier.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                         \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                         Nonusers EO Group: non-crack users who were not internal to the therapeutic communities (n=17),\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                         mean age of 24 years\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                         (± 0.7282)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                         Users EO Group, users of crack that were internal to the therapeutic communities (n=17), mean age of 30\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                         years (± 2,125).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Principal characteristics of clinical studies carried out with *Citrus sinensis* essential oil.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Authors**                **Indication**                                             **Study** **design**                                          **Subjects (number and age)**                                              **Treatment**                                                                                                                                                                                                **Principal endpoints**                                                                                                                                       **Adverse** **effects**   **Outcome**
  -------------------------- ---------------------------------------------------------- ------------------------------------------------------------- -------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Lehrner et al., 2000.      Anxiety in patients waiting for dental treatment.          Randomized controlled study                                   Total number of 72 patients;\                                              Participants were divided into two groups:\                                                                                                                                                                  To assess cognitive function, the Wortschatz test (WST) was used.\                                                                                            Not reported.             Relaxant effect of ambient orange odor exposure.\
                                                                                                                                                      age range: 22 - 57 years.\                                                 odor group: 18 men and 17 women.\                                                                                                                                                                            Postprocedural pain index was measured by visual analogue scale (VAS). State of anxiety was evaluated with the State Trait Anxiety Inventory (STAI) state.\                             Women exposed to\
                                                                                                                                                      Mean age Odor group: males 38.2 ± 9.6 years (age range 30-69 years);\      \                                                                                                                                                                                                            \                                                                                                                                                                                       orange odor had a lower level of state anxiety, a more\
                                                                                                                                                      females 32.5 ± 9.7 years (age range: 21-50 years).\                        control group: 14 men, 23 women\                                                                                                                                                                             For assessment of current mood, alertness, and calmness, the\                                                                                                                           positive mood, and a higher level of calmness.
                                                                                                                                                      Mean age No-odor group: males 31.4 ± 4.2 years (age range: 24-30years);\   \                                                                                                                                                                                                            Mehrdimensionale Befindlichkeitsfragebogen (MDBF) was used.\                                                                                                                            
                                                                                                                                                      females 34.6 ± 9.7 years (age range: 22-57 years)                          Ambient odor of orange was diffused in the waiting room through an electrical dispenser in the odor group whereas in the control group no odor was released in the air.\                                     \                                                                                                                                                                                       
                                                                                                                                                                                                                                 \                                                                                                                                                                                                            Mood, alertness,\                                                                                                                                                                       
                                                                                                                                                                                                                                 Every morning and every noon approximately 0.25 ml, corresponding to five drops, of essential oil was applied to the diffuser.                                                                               and calmness was evaluated with the five-point Likert scales.                                                                                                                           

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Jaafarzadeh et al., 2017   Child anxiety during dental treatment.                     Randomized, controlled, blinded, crossover, clinical trial.   30 children (10 boys, 20 girls).\                                          Patients were randomly assigned into two groups according to crossover design.\                                                                                                                              Anxiety of children was assessed with salivary cortisol level and pulse rate before and on completion of each of two dental treatment appointments.           Not reported              Statistically significant reduction of salivary cortisol level and pulse rate in aromatherapy group compared to control group.
                                                                                                                                                      Age range: 6-9 years.\                                                     First group: 15 children (9 girls and 6 boys); mean age 7.80 ± 0.86 years, treated in the absence of orange aroma in the first session (control) and under orange aroma in the second one (intervention).\                                                                                                                                                                                           
                                                                                                                                                      Mean age: 7.66 ± 0.84 years\                                               \                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                      First group mean age: 7.80 ± 0.86 years (treated).\                        Second group: 11 girls and 4 boys; mean age 7.53 ± 0.83 years, treated under orange aroma in the first encounter (intervention) and without odor in the second one (control).\                                                                                                                                                                                                                       
                                                                                                                                                      Second group mean age: 7.53 ± 0.83 years (control).\                       \                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                 2 ml of orange essence was placed in a dispenser activated for 2 min every 10 min.                                                                                                                                                                                                                                                                                                                   

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Costa Goes et al., 2012.   Healthy volunteers submitted to an anxiogenic situation.   Randomized, double-blind, placebo-controlled clinical\        40 males healthy graduate student volunteers.\                             The video-monitored Stroop Color-Word Test was used to elicit anxiety\                                                                                                                                       Psychologic parameters: STAI, Visual Analogue Mood Scale.\                                                                                                    Not reported              Individuals exposed to the test aroma (2.5 and 10 drops) presented a lack of significant alterations (p\> 0.05) in state-anxiety, subjective tension and tranquillity levels throughout the\
                                                                                        trial.                                                        Age range: 18-30 years.\                                                   in subjects participating in the study immediately after treatment.\                                                                                                                                         Physiologic parameters (heart rate and gastrocnemius electromyogram). Psychologic and physiologic parameters were evaluated before the inhalation\                                      anxiogenic situation, revealing a dose-dependent anxiolytic activity of sweet orange essential oil.
                                                                                                                                                                                                                                 Participants were divided into five groups treated as follows:\                                                                                                                                              period and before, during, and after the SCWT.                                                                                                                                          
                                                                                                                                                                                                                                 Test aroma. The test aroma consisted of essential oil of *C. sinensis* 2.5, 5, or 10 drops (SO~2.5~, SO~5~, SO~10~);\                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                 \                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                 control aroma: tea tree essential oil 2.5 drops;\                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                 nonaromatic control: The nonaromatic control was distilled water, 2.5 drops (H2O).                                                                                                                                                                                                                                                                                                                   
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

[Section 4](#sec4){ref-type="sec"} of elaborations of CONSORT items for trials with herbal medicine interventions applied to clinical studies with *Citrus aurantium* herbal preparations.

  **Reference**                    **Herbal medicinal product name**   **Characteristics of the herbal product**   **Dosage, regimen and quantitative description**   **Qualitative testing**   **Placebo/control group (rationale for control or placebo used)**   **Practitioner**         
  -------------------------------- ----------------------------------- ------------------------------------------- -------------------------------------------------- ------------------------- ------------------------------------------------------------------- ------------------ ----- -----
  Chaves Neto et al., 2017         Yes                                 Yes                                         Yes                                                Yes                       Yes                                                                 Yes                Yes   Yes
                                                                                                                                                                                                                                                                                             
  Fernandes Pimenta et al., 2016   Yes                                 Yes                                         Yes                                                Yes                       Yes                                                                 Yes                Yes   Yes
                                                                                                                                                                                                                                                                                             
  Namazi et al., 2014              Yes                                 Yes                                         No                                                 Yes                       Yes                                                                 No                 Yes   Yes
                                                                                                                                                                                                                                                                                             
  Hu et al., 2010                  No                                  No                                          No                                                 Yes                       Yes                                                                 No                 Yes   Yes
                                                                                                                                                                                                                                                                                             
  Hasheminia et al., 2014          Yes                                 No                                          No                                                 Yes                       Yes                                                                 No                 Yes   Yes
                                                                                                                                                                                                                                                                                             
  Akhlaghi et al., 2011            Yes                                 Yes                                         Yes                                                Yes                       Yes                                                                 Yes                Yes   Yes

###### 

[Section 4](#sec4){ref-type="sec"} of elaborations of CONSORT items for trials with herbal medicine interventions applied to clinical studies with *Citrussinensis* herbal preparations.

  **Reference**              **Herbal medicinal product name**   **Characteristics of the herbal product**   **Dosage, regimen and quantitative description**   **Qualitative testing**   **Placebo/control group (rationale for control or placebo used)**   **Practitioner**         
  -------------------------- ----------------------------------- ------------------------------------------- -------------------------------------------------- ------------------------- ------------------------------------------------------------------- ------------------ ----- -----
  Jaafarzadeh et al., 2017   Yes                                 Yes                                         Yes                                                Yes                       Yes                                                                 Yes                Yes   Yes
                                                                                                                                                                                                                                                                                       
  Costa Goes et al., 2012    Yes                                 No                                          Yes                                                Yes                       Yes                                                                 Yes                Yes   Yes
                                                                                                                                                                                                                                                                                       
  Lehrner et al., 2000       Yes                                 Yes                                         Yes                                                Yes                       Yes                                                                 Yes                Yes   Yes

###### 

Clinical trials quality assessment according to Jadad score.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
   \                         Authors                          Was the trial\             Was the\                     Was the trial\               Was the method\       Was the\                   Jadad Score
                                                              described as randomized?   randomization\               described as double-blind?   of double blinding\   number of\                 
                                                                                         procedure\                                                described and\        withdrawals/dropouts\      
                                                                                         described and appropriate?                                appropriate?          in each group mentioned?   
  -------------------------- -------------------------------- -------------------------- ---------------------------- ---------------------------- --------------------- -------------------------- -------------
  ***Citrus aurantium***     Fernandes Pimenta et al., 2016   Yes                        Yes                          No                           No                    No                         2

  Chaves Neto et al., 2017   Yes                              No                         No                           No                           No                    1                          

  Namazi et al., 2014        Yes                              Yes                        No                           No                           Yes                   3                          

  Pei-Hsin et al., 2010      Yes                              No                         No                           No                           No                    0                          

  Hasheminia et al., 2014    Yes                              Yes                        No                           No                           No                    2                          

  Akhlaghi et al., 2011      Yes                              Yes                        Yes                          Yes                          Yes                   5                          

                                                                                                                                                                                                    

  ***Citrus sinensis***      Lehrner et al., 2000             Yes                        No                           No                           No                    No                         0

  Jaafarzadeh et al., 2017   Yes                              Yes                        Yes                          No                           Yes                   3                          

  Costa Goes et al., 2012    Yes                              Yes                        Yes                          No                           Yes                   3                          
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The JADAD scoring system was used for the assessment of randomized controlled trials with the following 5 items:

Was the study described as randomized? (Yes = 1 point, No = 0 points);

Was the randomization scheme described and appropriate? (Yes = 1 point, No = -1 point);

Was the study described as double-blind? (Yes = 1 point, No = 0 points);

Was the method of double blinding appropriate? (Yes = 1 point, No = -1 point. If the answer of Item 3 was No, Item 4 is not calculable);

Was there a description of dropouts and withdrawals? (Yes = 1 point, No = 0 points).

[^1]: Academic Editor: Tadaaki Satou
